News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KKR (KKR) to Acquire ReSearch Pharmaceutical Services (RPS), Inc.


8/6/2013 7:21:59 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KKR (NYSE: KKR) announced the signing of a definitive agreement to acquire ReSearch Pharmaceutical Services Inc. (“RPS”), a leading global contract research organization (CRO), from Warburg Pincus. This follows an announcement on June 24, 2013 in which KKR announced the acquisition of another leading CRO, PRA International (“PRA”). Terms of the transaction were not disclosed. Upon close of both of the transactions, PRA and RPS will merge, with PRA Chief Executive Officer Colin Shannon leading the combined enterprise.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES